LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase

Breast Cancer Research · Published 2026-07-08 · DOI 10.1186/s13058-026-02343-3

Free full text

Authors (6)

Changjiao Yan, Fengqiang Cui, Chutuo Liu, Rui Ling, Meiling Huang, Ting Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yan, C., Cui, F., Liu, C., et al. (2026). LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase. Breast Cancer Research. https://doi.org/10.1186/s13058-026-02343-3

Related articles

• Artificial intelligence integrated multi-omics and multimodal studies promote the efficacy of neoadjuvant chemotherapy in breast cancer: opportunities, challenges, and future perspectives · Breast Cancer Research · 2026 · Same journal
• Targeting drug resistance in breast cancer: a dual-perspective landscape analysis of PROTACs from bench to bedside · Breast Cancer Research · 2026 · Same journal
• Predicting sentinel lymph node metastasis in breast cancer using an interpretable machine learning approach based on multi-domain clinical features · Breast Cancer Research · 2026 · Same journal
• CAF-derived exosomes drive trastuzumab resistance in HER2-positive breast cancer via YAP-USP8-HER2 axis activation · Breast Cancer Research · 2026 · Same journal
• Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling · Breast Cancer Research · 2026 · Same journal
• The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies · Breast Cancer Research · 2026 · Same journal
• Time-dependent anti-Müllerian hormone dynamics during GnRHa-based endocrine therapy in young breast cancer survivors: a longitudinal real-world cohort study · Breast Cancer Research · 2026 · Same journal
• Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome · Breast Cancer Research · 2026 · Same journal
• Transcriptome predictors of second breast events in ductal carcinoma in situ: a case‒control study including Black and White women · Breast Cancer Research · 2026 · Same journal
• Tumour-based DNA methylation markers of breast cancer survival: a pooled analysis of 2157 cases · Breast Cancer Research · 2026 · Same journal